Condition: Sinus Node Disease · Atrioventricular; Block, Second Degree (Types I and II) · Sponsor: Quovadis Associazione
A multicenter, prospective, randomized study in a 1:1 ratio, single-blind with double-blind evaluation to evaluate the superiority of physiological ventricular pacing (proposed modality) vs. managed ventricular pacing (control) for prevention of persistent AF (PeAF) occurrence in patients with prolonged atrioventricular interval (PR≥180 ms) and indication for pacing: sinus node disease and/or paroxysmal type 1 or 2-second degree AV block.
This description comes directly from the study's public registry record.
Gianni Pastore, MD · +39 (339) 754-4514 · gianni.pastore@aulss5.veneto.it
Franco Noventa, MD · franco.noventa@quovadis-ass.it
Always discuss trial participation with your own doctor first.
| Elettrofisiologia, Cardiologia, Ospedale di Rovigo | Rovigo, Veneto, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05367037